Literature DB >> 21786007

Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sjögren's syndrome in lupus-prone female NZB × NZWF(1) mice.

Toshiharu Hayashi1, Natsumi Shimoyama, Takuya Mizuno.   

Abstract

T helper (Th)1/Th2 balance determines the direction of some kinds of autoimmune diseases. The involvement of acini areas by CD4(+) helper T(Th) cell subset in submandibular and lacrimal glands are largely unknown in secondary Sjögren's syndrome (sSjS) with systemic lupus erythematosus (SLE). Submandibular and lacrimal glands were examined immunopathologically in lupus-prone female NZB × NZW(B/W)F(1) mice, model for human sSjS with SLE. Dacryoadenitis and sialoadenitis with renal failure developed with age. Infiltration of lymphoid cells (lymphocytes and plasma cells) expanded from the periductal areas in striated ducts to the acini, and the isolated foci in the acini were observed in those organs. The destruction of duct and acini epithelium, including the myoepithelium, was induced by interferon (IFN)-γ(+) and IgG2a(+) lymphoid cells, but not by interleukin(IL)-4(+), IL-5(+), IL-13(+), and IgG1(+) lymphoid cells. Compared with IL-5 and IL-13, high values of IFN-γ were produced systemically at various ages. Also local expression of IFN-γ mRNA was higher than that of IL-4 mRNA. The result suggests that the acini destruction in submandibular and lacrimal glands may be induced by systemic and local Th1 cell dominant reactions in lupus-prone B/WF(1) mice with sSjS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21786007     DOI: 10.1007/s10753-011-9356-y

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  34 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome.

Authors:  D I Mitsias; A G Tzioufas; C Veiopoulou; E Zintzaras; I K Tassios; O Kogopoulou; H M Moutsopoulos; G Thyphronitis
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

Review 3.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

4.  Single cell analysis of T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.

Authors:  I Matsumoto; S Okada; K Kuroda; I Iwamoto; Y Saito; T Tokuhisa; K Nishioka; T Sumida
Journal:  Int J Mol Med       Date:  1999-11       Impact factor: 4.101

5.  Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.

Authors:  Noriyoshi Ogawa; Li Ping; Li Zhenjun; Yukiko Takada; Susumu Sugai
Journal:  Arthritis Rheum       Date:  2002-10

6.  Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.

Authors:  D A Jabs; B Lee; J A Whittum-Hudson; R A Prendergast
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-03       Impact factor: 4.799

7.  Systemic treatment of anti-CD4CD25 T cell monoclonal antibody exacerbates sialoadenitis in submandibular glands during the early life in lupus-prone female NZB x NZWF mice.

Authors:  Toshiharu Hayashi; Chie Adachi; Keiko Hasegawa
Journal:  J Oral Pathol Med       Date:  2008-12-26       Impact factor: 4.253

8.  Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway.

Authors:  Alexander Espinosa; Valerie Dardalhon; Susanna Brauner; Aurelie Ambrosi; Rowan Higgs; Fransisco J Quintana; Maria Sjöstrand; Maija-Leena Eloranta; Joan Ní Gabhann; Ola Winqvist; Birgitta Sundelin; Caroline A Jefferies; Björn Rozell; Vijay K Kuchroo; Marie Wahren-Herlenius
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

9.  Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.

Authors:  Cuong Q Nguyen; Min H Hu; Yi Li; Carol Stewart; Ammon B Peck
Journal:  Arthritis Rheum       Date:  2008-03

Review 10.  Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.

Authors:  Toshiharu Hayashi
Journal:  J Biomed Biotechnol       Date:  2010-08-17
View more
  6 in total

Review 1.  T helper cytokines in dry eye disease.

Authors:  Stephen C Pflugfelder; Rosa M Corrales; Cintia S de Paiva
Journal:  Exp Eye Res       Date:  2013-09-04       Impact factor: 3.467

2.  A MZB Cell Activation Profile Present in the Lacrimal Glands of Sjögren's Syndrome-Susceptible C57BL/6.NOD-Aec1Aec2 Mice Defined by Global RNA Transcriptomic Analyses.

Authors:  Ammon B Peck; Cuong Q Nguyen; Julian L Ambrus
Journal:  Int J Mol Sci       Date:  2022-05-29       Impact factor: 6.208

3.  Protective role of commensal bacteria in Sjögren Syndrome.

Authors:  Mahira Zaheer; Changjun Wang; Fang Bian; Zhiyuan Yu; Humberto Hernandez; Rodrigo G de Souza; Ken T Simmons; Deborah Schady; Alton G Swennes; Stephen C Pflugfelder; Robert A Britton; Cintia S de Paiva
Journal:  J Autoimmun       Date:  2018-06-20       Impact factor: 7.094

Review 4.  Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.

Authors:  Terry G Coursey; Cintia S de Paiva
Journal:  Clin Ophthalmol       Date:  2014-08-04

5.  Sjögren-Like Lacrimal Keratoconjunctivitis in Germ-Free Mice.

Authors:  Changjun Wang; Mahira Zaheer; Fang Bian; Darin Quach; Alton G Swennes; Robert A Britton; Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Int J Mol Sci       Date:  2018-02-13       Impact factor: 5.923

6.  Cytokine/Chemokine/Growth Factor Profiles Contribute to Understanding the Pathogenesis of the Salivary Gland Dysfunction in Euthyroid Hashimoto's Thyroiditis Patients.

Authors:  K Morawska; M Maciejczyk; S Zięba; Ł Popławski; A Kita-Popławska; J Krętowski; A Zalewska
Journal:  Mediators Inflamm       Date:  2021-07-11       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.